查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750670

全球結構性心臟阻塞設備市場：市場規模、佔有率、趨勢分析（按類型、最終用途和地區）、細分市場預測（2025-2030 年）

Structural Heart Occlusion Devices Market Size, Share & Trends Analysis Report By Type (Left Atrial Appendage Occlusion Devices, Atrial Septal Defect Occluders), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年全球結構性心臟阻塞設備市場規模將達到 40 億美元，2025 年至 2030 年的複合年成長率將達到 7.0%。

結構性心臟阻塞設備市場受到結構性心臟病負擔日益加重、微創療法日益普及以及監管和報銷政策利好變化的驅動。臨床認知度的提升和手術流程的創新正在擴大患者群體，增強了強勁成長的前景。

結構性心臟病盛行率的上升是結構性心臟阻塞設備市場的主要驅動力。隨著診斷技術的不斷進步，心房中膈缺損症、卵圓孔未閉合和左心耳畸形等疾病正日益受到臨床關注。美國心臟協會2024年統計數據更新預測，美國心房顫動(AF)的盛行率將從2010年的約520萬增至2030年的1210萬，凸顯了臨床對有效干預措施日益成長的需求。隨著認知度的提高和診斷途徑的標準化，適合接受封堵治療的患者群體將顯著擴大，為市場成長奠定堅實的基礎。

隨著全球心房顫動 (AF) 盛行率持續上升，左心耳封堵器 (LAAO) 在結構性心臟阻塞設備市場中日益受到青睞。 LAAO 為非瓣膜性心房顫動患者（尤其是高出血風險患者）提供了一種非藥物性的口服抗凝血劑替代療法，用於預防中風。 2025 年 2 月發表於《歐洲心臟雜誌增刊》的一篇論文強調，對於長期口服抗凝血治療 (OAT) 禁忌的患者，LAAO 的應用日益廣泛。該論文強調，儘管 OAT 在預防中風方面發揮重要作用，但某些患者，尤其是有出血事件病史的患者，仍面臨較高的缺血性中風風險。

監管和報銷舉措在塑造結構性心臟阻塞設備市場方面發揮日益重要的作用。良好的政策環境對於鼓勵臨床應用、刺激創新投資以及擴大患者獲得先進療法的管道至關重要。 2025年3月，美國醫療保險和醫療補助服務中心 (CMS)核准了REDUCE-AF 臨床試驗，該試驗旨在評估 LAmbre Plus 左心耳封堵器在實證覆蓋 (CED) 框架下的療效。該決定體現了監管機構持續致力於建立強力的臨床證據，以支持該裝置在非瓣膜性心房顫動患者中的應用。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 結構性心臟阻塞設備市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 結構性心臟阻塞設備市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章。結構性心臟阻塞設備市場：按類型估計和趨勢分析

  • 結構性心臟阻塞設備市場：按類型分類的儀表板
  • 結構性心臟阻塞設備市場：按類型進行的變化分析
  • 結構性心臟阻塞設備市場：市場規模預測與趨勢分析（按類型）（2018-2030 年）
  • 左心耳（LAA）阻塞設備
  • 心房中隔缺損 (ASD)阻塞設備
  • 開放性動脈導管閉（PDA）阻塞設備
  • 其他

5. 結構性心臟阻塞設備市場：依最終用途的估計和趨勢分析

  • 結構性心臟阻塞設備市場：依最終用途分類的儀表板
  • 結構性心臟阻塞設備市場：依最終用途進行的變化分析
  • 結構性心臟阻塞設備市場：按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院
  • 專科診所
  • 學術研究所

6. 結構性心臟阻塞設備市場：區域估計和趨勢分析（按國家、類型、適應症和最終用途）

  • 全球結構性心臟阻塞設備市場：按地區分類
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 近期趨勢和影響分析：按主要製造商
  • 公司/競爭對手分類
  • 主要企業市場佔有率分析（2024年）
    • 雅培
    • 波士頓科學公司
    • 奧庫泰克
    • 先健科技
    • Medtronic
    • 戈爾公司
    • 瑞普醫療科技（北京）有限公司
    • M Tree Medical（Cardia 株式會社）
    • Biosense Webster（強生公司）
    • PFM醫療
Product Code: GVR-4-68040-566-5

Market Size & Trends:

The global structural heart occlusion devices market size was estimated at USD 4.0 billion in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2030. The structural heart occlusion devices market is advancing due to the rising burden of structural heart diseases, increasing acceptance of minimally invasive therapies, and favorable regulatory and reimbursement changes. Growing clinical awareness and procedural innovations are expanding the eligible patient pool, reinforcing a strong positive growth outlook.

The increasing prevalence of structural heart diseases is a major driver for the structural heart occlusion devices market. Conditions such as atrial septal defects, patent foramen ovale, and left atrial appendage abnormalities are gaining greater clinical attention as diagnostic technologies continue to advance. The American Heart Association's 2024 Statistical Update projects that the prevalence of atrial fibrillation (AF) in the U.S. will rise from approximately 5.2 million in 2010 to 12.1 million by 2030, underscoring the growing clinical need for effective interventions. As awareness improves and diagnostic pathways become more standardized, the addressable patient population for occlusion therapies is expanding significantly, creating a strong foundation for market growth.

As the prevalence of atrial fibrillation (AF) continues to rise globally, Left Atrial Appendage Occlusion (LAAO) procedures are gaining traction within the Structural Heart Occlusion Devices market. LAAO offers a non-pharmacologic alternative to oral anticoagulants for stroke prevention in patients with non-valvular AF, particularly those at high bleeding risk. A February 2025 article published in the European Heart Journal Supplements focused on the growing adoption of LAAO for patients with contraindications to long-term oral anticoagulant therapy (OAT). The article emphasizes that despite OAT's role in stroke prevention, certain patients, especially those with a history of bleeding events, remain at high risk for ischemic strokes.

Regulatory and reimbursement initiatives are playing an increasingly important role in shaping the structural heart occlusion devices market. Favorable policy environments are essential to encourage clinical adoption, promote investment in innovation, and expand patient access to advanced therapies. In March 2025, the Centers for Medicare & Medicaid Services (CMS) approved the REDUCE-AF clinical trial under Coverage with Evidence Development (CED) to evaluate the LAmbre Plus Left Atrial Appendage Closure System. This decision reflects continued regulatory emphasis on building robust clinical evidence to support device utilization in patients with non-valvular atrial fibrillation.

Global Structural Heart Occlusion Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global structural heart occlusion devices market report based on type, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Left Atrial Appendage (LAA) Occlusion Devices
  • Atrial Septal Defect (ASD) Occluders
  • Patent Ductus Arteriosus (PDA) Occlusion Devices
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty clinics
  • Academic and Research Institutes
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Structural Heart Occlusion Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of structural heart diseases
      • 3.2.1.2. Growth of minimally invasive cardiac interventions
      • 3.2.1.3. Regulatory and reimbursement tailwinds
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory approval delays
  • 3.3. Structural Heart Occlusion Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Structural Heart Occlusion Devices Market: Type Estimates & Trend Analysis

  • 4.1. Structural Heart Occlusion Devices Market: Type Dashboard
  • 4.2. Structural Heart Occlusion Devices Market: Type Movement Analysis
  • 4.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Left Atrial Appendage (LAA) Occlusion Devices
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Atrial Septal Defect (ASD) Occluders
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Patent Ductus Arteriosus (PDA) Occlusion Devices
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Structural Heart Occlusion Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Structural Heart Occlusion Devices Market: End Use Dashboard
  • 5.2. Structural Heart Occlusion Devices Market: End Use Movement Analysis
  • 5.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Academic and Research Institutes
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Structural Heart Occlusion Devices Market: Regional Estimates & Trend Analysis by Country, Type, Indication, & End Use

  • 6.1. Global Structural Heart Occlusion Devices Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2024
    • 7.3.1. Abbott
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Boston Scientific Corporation
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Occlutech
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Lifetech Scientific
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. W. L. Gore & Associates
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Lepu Medical Technology (Beijing)Co.,Ltd
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Emtree Medical (Cardia Inc.)
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Biosense Webster (Johnson & Johnson)
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. PFM Medical GMBH
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global structural heart occlusion devices market, by type 2018 - 2030 (USD Million)
  • Table 4 Global structural heart occlusion devices market, by end use, 2018 - 2030
  • Table 5 Global structural heart occlusion devices market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Mexico structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 17 Europe structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 18 UK structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 19 UK structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 23 France structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Italy structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 25 Italy structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Spain structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 27 Spain structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 29 Denmark structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 31 Sweden structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Norway structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 33 Norway structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Japan structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 38 Japan structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 39 China structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 China structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41 India structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 42 India structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Australia structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 44 Australia structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 47 Thailand structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 48 South Korea structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 49 South Korea structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 52 Latin America structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 54 Brazil structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 56 Argentina structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 57 MEA structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
  • Table 58 MEA structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 MEA structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Africa structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 65 UAE structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Participant's overview
  • Table 69 Financial performance
  • Table 70 Key companies undergoing expansions
  • Table 71 Key companies undergoing acquisitions
  • Table 72 Key companies undergoing collaborations
  • Table 73 Key companies launching new products
  • Table 74 Key companies undergoing partnerships
  • Table 75 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Structural heart occlusion devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Structural heart occlusion devices market revenues, 2024 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Structural heart occlusion devices market Type outlook:
  • Fig. 14 Structural heart occlusion devices market: Type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global left atrial appendage (LAA) occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 17 Global atrial septal defect (ASD) occluders market, 2018 - 2030 (USD Million)
  • Fig. 18 Global patent ductus arteriosus (PDA) occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 19 Global others market, 2018 - 2030 (USD Million)
  • Fig. 20 Structural heart occlusion devices market end use outlook:
  • Fig. 21 Structural heart occlusion devices market: end use movement analysis
  • Fig. 22 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 23 Global specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 24 Global academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 25 Regional market place: Key takeaways
  • Fig. 26 North America structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Europe structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Germany structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 32 UK structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 33 France structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Italy structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Spain structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Norway structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Japan structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 41 China structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 42 India structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Australia structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 49 MEA structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait structural heart occlusion devices market, 2018 - 2030 (USD Million)
  • Fig. 54 Market Participant Categorization
  • Fig. 55 Strategy mapping